Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Paolo Morgagni"'
Autor:
Massimo Framarini, Fabrizio D’Acapito, Daniela Di Pietrantonio, Francesca Tauceri, Giovanni Vittimberga, Leonardo Solaini, Giulia Elena Cantelli, Giulia Marchetti, Paolo Morgagni, Giorgio Ercolani
Publikováno v:
Surgeries, Vol 5, Iss 2, Pp 465-475 (2024)
Gastric cancer (GC) is the fifth most diagnosed cancer, but it is the third leading cause of cancer death worldwide. Despite the likelihood of gastric cancer metastasizing to the peritoneum, optimal management strategies for this population remain un
Externí odkaz:
https://doaj.org/article/fa30579b2db34fecbe57ac34e347dac4
Autor:
Mariagiulia Dal Cero, Joan Gibert, Luis Grande, Marta Gimeno, Javier Osorio, Maria Bencivenga, Uberto Fumagalli Romario, Riccardo Rosati, Paolo Morgagni, Suzanne Gisbertz, Wojciech P. Polkowski, Lucio Lara Santos, Piotr Kołodziejczyk, Wojciech Kielan, Rossella Reddavid, Johanna W. van Sandick, Gian Luca Baiocchi, Ines Gockel, Andrew Davies, Bas P. L. Wijnhoven, Daniel Reim, Paulo Costa, William H. Allum, Guillaume Piessen, John V. Reynolds, Stefan P. Mönig, Paul M. Schneider, Elisenda Garsot, Emma Eizaguirre, Mònica Miró, Sandra Castro, Coro Miranda, Xavier Monzonis-Hernández, Manuel Pera, on behalf of the Spanish EURECCA Esophagogastric Cancer Group and the European GASTRODATA Study Group
Publikováno v:
Cancers, Vol 16, Iss 13, p 2463 (2024)
Background: Radical gastrectomy remains the main treatment for gastric cancer, despite its high mortality. A clinical predictive model of 90-day mortality (90DM) risk after gastric cancer surgery based on the Spanish EURECCA registry database was dev
Externí odkaz:
https://doaj.org/article/512cdc1d1ebd4fa3956cf82f6ec8f73c
Autor:
Zuzanna Pelc, Katarzyna Sędłak, Magdalena Leśniewska, Katarzyna Mielniczek, Katarzyna Chawrylak, Magdalena Skórzewska, Tomasz Ciszewski, Joanna Czechowska, Agata Kiszczyńska, Bas P. L. Wijnhoven, Johanna W. Van Sandick, Ines Gockel, Suzanne S. Gisbertz, Guillaume Piessen, Clarisse Eveno, Maria Bencivenga, Giovanni De Manzoni, Gian Luca Baiocchi, Paolo Morgagni, Riccardo Rosati, Uberto Fumagalli Romario, Andrew Davies, Yutaka Endo, Timothy M. Pawlik, Franco Roviello, Christiane Bruns, Wojciech P. Polkowski, Karol Rawicz-Pruszyński
Publikováno v:
Cancers, Vol 16, Iss 9, p 1721 (2024)
The incidence of gastric cancer (GC) is expected to increase to 1.77 million cases by 2040. To improve treatment outcomes, GC patients are increasingly treated with neoadjuvant chemotherapy (NAC) prior to curative-intent resection. Although NAC enhan
Externí odkaz:
https://doaj.org/article/cf604c2325054ab1b0bd15e1a2da7c9f
Autor:
Maria Bencivenga, Silvia Ministrini, Paolo Morgagni, Gianni Mura, Daniele Marrelli, Carlo Milandri, Maria Antonietta Mazzei, Mattia Berselli, Manlio Monti, Luigina Graziosi, Rossella Reddavid, Fausto Rosa, Leonardo Solaini, Annibale Donini, Uberto Fumagalli Romario, Franco Roviello, Giovanni de Manzoni, Guido Alberto Massimo Tiberio
Publikováno v:
Cancers, Vol 16, Iss 1, p 170 (2023)
Background: Interest in the field of metastatic gastric cancer has grown in recent years, and the identification of oligometastatic patients plays a critical role as it consents to their inclusion in multimodal treatment strategies, which include sys
Externí odkaz:
https://doaj.org/article/9a5b534f43504d7388d2eec5cbce625a
Autor:
Manlio Monti, Andrea Prochowski Iamurri, David Bianchini, Chiara Gallio, Luca Esposito, Daniela Montanari, Silvia Ruscelli, Chiara Molinari, Flavia Foca, Alessandro Passardi, Giovanni Vittimberga, Paolo Morgagni, Giovanni Luca Frassineti
Publikováno v:
Nutrients, Vol 15, Iss 16, p 3604 (2023)
Background and aims: Perioperative treatment is currently the gold standard approach in Europe for locally advanced gastric cancer (GC). Unfortunately, the phenomenon of patients dropping out of treatment has been frequently observed. The primary aim
Externí odkaz:
https://doaj.org/article/238e8a0066f048579c7fe243a6573d6a
Autor:
Luigina Graziosi, Elisabetta Marino, Maria Bencivenga, Alessia D’Ignazio, Leonardo Solaini, Silvia Ministrini, Michela Caprioli, Michele Sacco, Daniele Marrelli, Gianni Mura, Maurizio Degiuli, Paolo Morgagni, Guido Alberto Massimo Tiberio, Giovanni De Manzoni, Franco Roviello, Annibale Donini
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background The present study provides a snapshot of Italian patients with peritoneal metastasis from gastric cancer treated by surgery in Italian centers belonging to the Italian Research Group on Gastric Cancer. Prognostic factors affecting
Externí odkaz:
https://doaj.org/article/90919a9b596149e895affa76b44be0e7
Autor:
Paolo Morgagni, Leonardo Solaini, Luca Saragoni, Manlio Monti, Martina Valgiusti, Giovanni Vittimberga, Giovanni Luca Frassineti, Massimo Framarini, Giorgio Ercolani
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAfter the REGATTA trial, patients with stage IV gastric cancer could only benefit from chemotherapy (CHT). However, some of these patients may respond extraordinarily to palliative chemotherapy, converting their disease to a radically opera
Externí odkaz:
https://doaj.org/article/e47ab252159a412e9c5d0c9d34829482
Autor:
Massimiliano Salati, Nicola De Ruvo, Mariano Cesare Giglio, Lorena Sorrentino, Giuseppe Esposito, Sara Fenocchi, Giovanni Cucciarrè, Francesco Serra, Elena Giulia Rossi, Giovanni Vittimberga, Giorgia Radi, Leonardo Solaini, Paolo Morgagni, Giulia Grizzi, Margherita Ratti, Fabio Gelsomino, Andrea Spallanzani, Michele Ghidini, Giorgio Ercolani, Massimo Dominici, Roberta Gelmini
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 18, p 5439 (2022)
Background. More than 50% of operable GEA relapse after curative-intent resection. We aimed at externally validating a nomogram to enable a more accurate estimate of individualized risk in resected GEA. Methods. Medical records of a training cohort (
Externí odkaz:
https://doaj.org/article/0ef368dc5e7c4d04977eb339db3ce355
Autor:
Gianluca Tedaldi, Chiara Molinari, Celina São José, Rita Barbosa-Matos, Ana André, Rita Danesi, Valentina Arcangeli, Mila Ravegnani, Luca Saragoni, Paolo Morgagni, Francesca Rebuzzi, Matteo Canale, Sara Pignatta, Elisa Ferracci, Giovanni Martinelli, Guglielmina Nadia Ranzani, Carla Oliveira, Daniele Calistri, Paola Ulivi
Publikováno v:
Pharmaceuticals, Vol 14, Iss 5, p 457 (2021)
E-cadherin is a key player in gastric cancer (GC) and germline alterations of CDH1, its encoding gene, are responsible for Hereditary Diffuse Gastric Cancer (HDGC) syndrome. This study aimed at elucidating the role of genetic variants and DNA methyla
Externí odkaz:
https://doaj.org/article/93314491ddb043b1bf1a47a691c33b20
Autor:
Manlio Monti, Paolo Morgagni, Oriana Nanni, Massimo Framarini, Luca Saragoni, Daniele Marrelli, Franco Roviello, Roberto Petrioli, Uberto Fumagalli Romario, Lorenza Rimassa, Silvia Bozzarelli, Annibale Donini, Luigina Graziosi, Verena De Angelis, Giovanni De Manzoni, Maria Bencivenga, Valentina Mengardo, Emilio Parma, Carlo Milandri, Gianni Mura, Alessandra Signorini, Gianluca Baiocchi, Sarah Molfino, Giovanni Sgroi, Francesca Steccanella, Stefano Rausei, Ilaria Proserpio, Jacopo Viganò, Silvia Brugnatelli, Andrea Rinnovati, Stefano Santi, Giorgio Ercolani, Flavia Foca, Linda Valmorri, Dino Amadori, Giovanni Luca Frassineti
Publikováno v:
Cancers, Vol 12, Iss 10, p 2790 (2020)
Docetaxel associated with oxaliplatin and 5-fluorouracil (FLOT) has been reported as the best perioperative treatment for gastric cancer. However, there is still some debate about the most appropriate number and timing of chemotherapy cycles. In this
Externí odkaz:
https://doaj.org/article/c801bee84a2f4a2ba6342b1baeb6c7cd